Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Omnipod® 5 With Libre 2 vs. MDI for Type 1 Diabetes in Children and Adults

NCT: NCT05923827 · COMPLETED

NCT IDNCT05923827
StatusCOMPLETED
Start Date2023-09-11
Completion2026-02-12

Brief Summary

This study is a randomized, controlled trial to evaluate the efficacy and safety of the Omnipod® 5 System with the FreeStyle Libre 2 continuous glucose monitor compared to Multiple Daily Injections (MDI) along with the FreeStyle Libre 2 continuous glucose monitor in children and adults with type 1 diabetes.

Frequently Asked Questions

What is Omnipod® 5 With Libre 2 vs. MDI for Type 1 Diabetes in Children and Adults?

Omnipod® 5 With Libre 2 vs. MDI for Type 1 Diabetes in Children and Adults is a clinical trial registered under NCT05923827. Current status: COMPLETED.

What is the status of NCT05923827?

The current status of NCT05923827 (Omnipod® 5 With Libre 2 vs. MDI for Type 1 Diabetes in Children and Adults) is: COMPLETED.

When did Omnipod® 5 With Libre 2 vs. MDI for Type 1 Diabetes in Children and Adults start?

Omnipod® 5 With Libre 2 vs. MDI for Type 1 Diabetes in Children and Adults started on 2023-09-11.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑